Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge

Research in Veterinary Science

Volumn 95, Issue 3, 2013, Pages 1217-1223

  Bhat, S A ^a   Saravanan, P ^a   Hosamani, M ^a   Basagoudanavar, S H ^a   Sreenivasa, B P ^a   Tamilselvan, R P ^a   Venkataramanan, R ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Baculovirus expression system; Foot and mouth disease virus; Protection against challenge; Virus like particles; Virus neutralizing antibody

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; BACULOVIRUS; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FOOT AND MOUTH DISEASE VIRUS; GUINEA PIG; HUMORAL IMMUNITY; IMMUNOGENICITY; MALE; NONHUMAN; VIRUS EXPRESSION; VIRUS LIKE AGENT; VIRUS NEUTRALIZATION; VIRUS VIRULENCE;

CAVIA; FOOT-AND-MOUTH DISEASE VIRUS;

BACULOVIRUS EXPRESSION SYSTEM; FOOT-AND-MOUTH DISEASE VIRUS; PROTECTION AGAINST CHALLENGE; VIRUS LIKE PARTICLES; VIRUS NEUTRALIZING ANTIBODY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; BACULOVIRIDAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MALE; NEUTRALIZATION TESTS; VACCINES, SYNTHETIC; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES;

EID: 84888008597     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2013.07.007     Document Type: Article

References (25)

1. Anon Annual Report 2009-2010 Project Directorate on Foot and Mouth Disease 2010, ICAR, Mukteswar, Uttarakhand, India, p. 5.
2. Balamurugan V., Kumar R.M., Suryanarayana V.V. Past and present vaccine development strategies for the control of foot-and-mouth disease. Acta Virologica 2004, 48:201-214.
3. Belsham G.J., McInerney G.M., Ross-Smith N. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. Journal of Virology 2000, 74:272-280.
4. Brun A., Barcena J., Blanco E., Borrego B., Dory D., Escribano J.M., Le Gall-Recule G., Ortego J., Dixon L.K. Current strategies for subunit and genetic viral veterinary vaccine development. Virus Research 2011, 157:1-12.
5. Cao Y., Lu Z., Sun J., Bai X., Sun P., Bao H., Chen Y., Guo J., Li D., Liu X., Liu Z. Synthesis of empty capsid-like particles of Asia1 foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs. Veterinary Microbiology 2009, 137:10-17.
6. Cao Y., Sun P., Fu Y., Bai X., Tian F., Liu X., Lu Z., Liu Z. Formation of virus-like particles from O-type foot-and-mouth disease virus in insect cells using codon-optimized synthetic genes. Biotechnology Letters 2010, 32:1223-1229.
7. Carr B.V., Lefevre E.A., Windsor M.A., Inghese C., Gubbins S., Prentice H., Juleff N.D., Charleston B. CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle. Journal of General Virology 2012, 94:97-107.
8. Charleston B., Bankowski B.M., Gubbins S., Chase-Topping M.E., Schley D., Howey R., Barnett P.V., Gibson D., Juleff N.D., Woolhouse M.E. Relationship between clinical signs and transmission of an infectious disease and the implications for control. Science 2011, 332:726-729.
9. Falk M.M., Grigera P.R., Bergmann I.E., Zibert A., Multhaup G., Beck E. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. Journal of Virology 1990, 64:748-756.
10. Grubman M.J., Moraes M.P., Diaz-San Segundo F., Pena L., de los Santos T. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunology and Medical Microbiology 2008, 53:8-17.
11. Hu Y.C., Hsu J.T., Huang J.H., Ho M.S., Ho Y.C. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnology Letters 2003, 25:919-925.
12. Klopfleisch C., Minh L.Q., Giesow K., Curry S., Keil G.M. Effect of foot-and-mouth disease virus capsid precursor protein and 3C protease expression on bovine herpesvirus 1 replication. Archives of Virology 2010, 155:723-731.
13. Ko Y.J., Choi K.S., Nah J.J., Paton D.J., Oem J.K., Wilsden G., Kang S.Y., Jo N.I., Lee J.H., Kim J.H., Lee H.W., Park J.M. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay. Clinical and Diagnostic Laboratory Immunology 2005, 12:922-929.
14. Ko Y.J., Lee H.S., Jeoung H.Y., Heo E.J., Ko H.R., Chang B.S., Joo H.D., Gerelmaa U., Dashzeveg B., Tserendorj S., Sodnomdarjaa R., Park J.H., Kweon C.H., Cho I.S., Paik S.G. Use of a baculovirus-expressed structural protein for the detection of antibodies to foot-and-mouth disease virus type A by a blocking enzyme-linked immunosorbent assay. Clinical and Vaccine Immunology 2010, 17:194-198.
15. Kushnir N., Streatfield S.J., Yusibov V. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 2012, 31:58-83.
16. Mohana Subramanian B., Madhanmohan M., Sriraman R., Chandrasekhar Reddy R.V., Yuvaraj S., Manikumar K., Rajalakshmi S., Nagendrakumar S.B., Rana S.K., Srinivasan V.A. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency. Antiviral Research 2012, 96:288-295.
17. Oem J.K., Park J.H., Lee K.N., Kim Y.J., Kye S.J., Park J.Y., Song H.J. Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA. Vaccine 2007, 25:4112-4121.
18. OIE, 2009. OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Foot-and-mouth disease. <. (accessed 20.11.2012). http://www.oie.int/eng/A_FMD2012/docs/2.01.05_FMD.pdf.
19. OIE/FAO., 2010. FMD Reference Laboratory Network Annual Report 2010, pp75.
20. Porta C., Xu X., Loureiro S., Paramasivam S., Ren J., Al-Khalil T., Burman A., Jackson T., Belsham G.J., Curry S., Lomonossoff G.P., Parida S., Paton D., Li Y., Wilsden G., Ferris N., Owens R., Kotecha A., Fry E., Stuart D.I., Charleston B., Jones I.M. Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. Journal of Virological Methods 2013, 187:406-412.
21. Roy P., Noad R. Virus-like particles as a vaccine delivery system: myths and facts. Advances in Experimental Medicine and Biology 2009, 655:145-158.
22. Stewart M., Dubois E., Sailleau C., Breard E., Viarouge C., Desprat A., Thiery R., Zientara S., Roy P. Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen. Vaccine 2013, 31:553-558.
23. Urakawa T., Ferguson M., Minor P.D., Cooper J., Sullivan M., Almond J.W., Bishop D.H. Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector. Journal of General Virology 1989, 70:1453-1463.
24. Valarcher J.F., Leforban Y., Rweyemamu M., Roeder P.L., Gerbier G., Mackay D.K., Sumption K.J., Paton D.J., Knowles N.J. Incursions of foot-and-mouth disease virus into Europe between 1985 and 2006. Transboundary and Emerging Diseases 2008, 55:14-34.
25. Xiang J., Wunschmann S., George S.L., Klinzman D., Schmidt W.N., LaBrecque D.R., Stapleton J.T. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays. Journal of Medical Virology 2002, 68:537-543.